Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials

OBJECTIVE: To evaluate the potential effects of proprotein convertase subtilisin/kexin type 9 monoclonal antibody (PCSK9-mAb) on high-sensitivity C reactive protein (hs-CRP) concentrations. DESIGN: A systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: PubMed, MEDLINE,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ye-Xuan, Li, Sha, Liu, Hui-Hui, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173233/
https://www.ncbi.nlm.nih.gov/pubmed/30287608
http://dx.doi.org/10.1136/bmjopen-2018-022348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173233/
https://www.ncbi.nlm.nih.gov/pubmed/30287608
http://dx.doi.org/10.1136/bmjopen-2018-022348

Ejemplares similares